Cargando…
Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
Strontium ranelate (SrRan) is a drug usually prescribed to treat osteoporosis, with proven effects of decreasing the risk of fractures and an indication of reducing the progression of osteoarthritis (OA). This study aimed to investigate the effects of SrRan as either a prophylactic or a treatment dr...
Autores principales: | Rodrigues, T.A., Sampaio, A.J.B., Nunes, I.D.P., Cartágenes, M.S.S., Garcia, J.B.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572847/ https://www.ncbi.nlm.nih.gov/pubmed/28793056 http://dx.doi.org/10.1590/1414-431X20176314 |
Ejemplares similares
-
Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
por: Rodrigues, T.A., et al.
Publicado: (2018) -
Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
por: Rodrigues, Thiago A., et al.
Publicado: (2018) -
Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
por: Paulino Silva, Kássya Mycaela, et al.
Publicado: (2021) -
Polymeric strontium ranelate nonahydrate
por: Stahl, Kenny, et al.
Publicado: (2011) -
Cardiac concerns associated with strontium ranelate
por: Reginster, Jean-Yves
Publicado: (2014)